
Avient Corp (AVNT) Stock Forecast & Price Target
Avient Corp (AVNT) Analyst Ratings
Bulls say
Avient Corp has experienced a 5% increase in organic sales, indicating a robust demand for its product offerings in the Color, Additives and Inks, and Specialty Engineered Materials segments. Notably, the healthcare sector has shown impressive growth, with sales rising 14% year-over-year in the first half of 2025, sustained by double-digit growth for six consecutive quarters. Additionally, four out of nine end markets, which account for 40% of the company’s sales, are demonstrating growth this year, suggesting a diversified portfolio positioned favorably against ongoing market trends.
Bears say
Avient Corp has experienced a decline in organic sales, starting with a 2% decrease in the first quarter of 2024, followed by fluctuations in subsequent quarters that suggest inconsistent demand recovery. The company's performance in the chemicals sector has been adversely affected by weakening demand since mid-2025, raising concerns about potential volume risks in the second half of that year. Despite a favorable exchange rate environment from a declining U.S. dollar, the underlying negative trends in sales and demand do not provide a strong foundation for positive growth prospects.
This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.
Avient Corp (AVNT) Analyst Forecast & Price Prediction
Start investing in Avient Corp (AVNT)
Order type
Buy in
Order amount
Est. shares
0 shares